COMP <GO>
CCM vs MRK // NET PROFIT MARGIN
Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CCM 1
— MRK 9
▲ NET PROFIT MARGIN LEADER: MRK
CCM — Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)
ROARABLE E • RQD 22/100
LAST: $3.66 (-4.93%) • MKT CAP: $15.9M
net-margins
-20.40%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCM VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CCM | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 5.70% | 74.80% | -69.10 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.70% | -55.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -57.60% | 34.30% | -91.90 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -20.40% | 28.10% | -48.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 26.60% | 1.30% | +25.30 | CCM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 51.7 | -4.12 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.9M | $361.02B | -$361.01B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CCM REV | MRK REV | CCM GROSS % | MRK GROSS % | CCM FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.0M | $65.01B | 5.7% | 74.8% | -$36.9M | $12.36B |
| FY 2024 | $51.3M | $64.17B | -21.1% | 76.3% | -$75.1M | $18.10B |
| FY 2023 | $73.3M | $60.12B | — | — | -$38.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCM // BETA —
MRK // BETA 0.92